Physician profile
Lin Li
NPI 1497141717
$1,191.00
in general payments reported to CMS, 2019-2025
14 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $440 · 2024: $751.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $751.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $751.20 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biotronik INC. | $751.20 | 2024 | Selectra, Solia, Pamira |
| Allergan, INC. | $70.52 | 2020 | |
| Novo Nordisk INC | $68.57 | 2020 | |
| Astrazeneca Pharmaceuticals Lp | $63.27 | 2020 | |
| Pfizer INC. | $56.39 | 2020 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $37.51 | 2020 | |
| Lilly USA, LLC | $36.63 | 2020 | |
| Amarin Pharma, INC. | $22.96 | 2020 | |
| Astellas Pharma US INC | $17.94 | 2020 | |
| Genentech USA, INC. | $16.26 | 2020 | |
| Eisai INC. | $16.24 | 2020 | |
| Merck Sharp & Dohme LLC | $11.36 | 2020 | |
| Janssen Pharmaceuticals, INC | $11.17 | 2020 | |
| Antares Pharma, INC. | $10.98 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lin Li listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.